Dyadic International, Inc.

DYAI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $961.1K $1.1M $565.5K $1.2M $966.6K $393.6K $817.4K $2.0M
Cost of Revenue $984.2K $791.8K $384.6K $1.0M $613.6K $297.7K $352.8K $395.9K
Gross Profit $-23.0K $319.1K $180.9K $140.6K $353.0K $95.9K $464.6K $1.6M
Gross Margin -2.4% 28.7% 32.0% 12.1% 36.5% 24.4% 56.8% 79.8%
Operating Expenses
Research & Development $332.6K $476.1K $458.4K $571.9K $629.4K $495.0K $545.7K $460.2K
SG&A Expense $1.7M $1.8M $1.2M $1.5M $1.4M $1.6M $1.4M $1.3M
Operating Income $-2.1M $-1.9M $-1.5M $-1.9M $-1.7M $-2.0M $-1.5M $-202.6K
Operating Margin -213.7% -171.3% -271.6% -165.3% -178.9% -508.8% -187.2% -10.4%
Interest Expense — — — — — — — —
Pretax Income — — — — — — — —
Income Tax Expense — $0 — — — — — —
Net Income $-2.1M $-2.0M $-1.6M $-2.0M $-1.8M $-2.0M $-1.6M $-203.5K
Net Margin -221.0% -175.9% -277.1% -169.7% -185.6% -515.2% -189.7% -10.4%
EPS (Basic) $-0.06 $-0.05 $-0.04 $-0.06 $-0.06 $-0.07 $-0.05 $-0.01
EPS (Diluted) $-0.06 $-0.05 $-0.04 $-0.06 $-0.06 $-0.07 — $-0.01
Shares Outstanding (Basic) — — — — — — — —
Shares Outstanding (Diluted) 36.4M 36.4M 32.6M 34.5M 30.1M 29.9M 29.3M 29.5M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 5 Older →